Quidelortho Corp (OQ:QDEL)

Business Focus: Medical Diagnostic & Testing Equipment

Apr 26, 2024 02:15 pm ET
QuidelOrtho Corporation f/k/a Quidel Corporation Class Action: Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 26, 2024 02:15 pm ET
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 26, 2024 01:30 pm ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 26, 2024 12:45 pm ET
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 26, 2024 12:45 pm ET
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 26, 2024 12:07 pm ET
DEADLINE ALERT for VFS, QDEL, and ASTS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Apr 26, 2024 10:30 am ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 11, 2024 in QuidelOrtho Lawsuit - QDEL
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 26, 2024 10:15 am ET
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class Action - QDEL
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 26, 2024 05:45 am ET
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - QDEL
NEW YORK, April 26, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL).
Apr 25, 2024 08:45 pm ET
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join – Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 25, 2024 08:40 pm ET
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 25, 2024 07:45 pm ET
Contact Levi & Korsinsky by June 11, 2024 Deadline to Join Class Action Against QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 25, 2024 06:48 pm ET
Dicello Levitt LLP Announces Investor Class Action Lawsuit Filed Against QuidelOrtho Corp. f/k/a Quidel Corp. (NASDAQ: QDEL) And Lead Plaintiff Deadline
DiCello Levitt LLP announces that purchasers or acquirers of QuidelOrtho Corporation f/k/a Quidel Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) common stock between February 18, 2022, and April 1, 2024, inclusive (the “Class Period”)...
Apr 25, 2024 05:45 pm ET
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights – QDEL
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 25, 2024 05:45 pm ET
Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights – QDEL
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 25, 2024 04:40 pm ET
QDEL Investors Have Opportunity to Lead QuidelOrtho Corporation Securities Fraud Lawsuit
BENSALEM, Pa., April 25, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") (NASDAQ: QDEL).
Apr 25, 2024 03:30 pm ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 11, 2024 in QuidelOrtho Lawsuit - QDEL
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 25, 2024 03:15 pm ET
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 25, 2024 02:41 pm ET
QuidelOrtho (QDEL) Securities Fraud Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 18, 2022 – Apr. 1, 2024 Lead Plaintiff Deadline: June 11, 2024 Visit:...
Apr 25, 2024 02:00 pm ET
Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 25, 2024 02:00 pm ET
Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 25, 2024 01:15 pm ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 24, 2024 09:00 pm ET
June 11, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against QDEL
NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 24, 2024 08:23 pm ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 24, 2024 04:25 pm ET
QuidelOrtho Corporation f/k/a Quidel Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights – QDEL
NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 24, 2024 03:49 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL
Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or...
Apr 24, 2024 02:15 pm ET
QuidelOrtho Corporation f/k/a Quidel Corporation Class Action: Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL
NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 24, 2024 01:29 pm ET
DEADLINE ALERT for HRT, CKPT, SOND, QDEL: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Apr 24, 2024 12:15 pm ET
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 24, 2024 12:15 pm ET
Levi & Korsinsky Reminds QuidelOrtho Corporation f/k/a Quidel Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL
NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 24, 2024 11:30 am ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation (“QuidelOrtho” or “the Company”) (NASDAQ: QDEL) for violations of §§10(b) and 20(a) of the Securities...
Apr 24, 2024 08:15 am ET
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Shareholders
NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 24, 2024 08:15 am ET
Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - QDEL
NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 23, 2024 09:35 pm ET
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 23, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 23, 2024 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, and Sharecare and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ocugen, Inc. (NASDAQ: OCGN), QuidelOrtho Corporation (NASDAQ: QDEL), and...
Apr 23, 2024 05:20 pm ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 11, 2024 in QuidelOrtho Lawsuit - QDEL
NEW YORK, NY / ACCESSWIRE / April 23, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 23, 2024 05:20 pm ET
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 23, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 23, 2024 12:00 pm ET
Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / April 23, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 23, 2024 11:15 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, April 23, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ: QDEL) for violations of the securities laws.
Apr 23, 2024 05:30 am ET
Contact Levi & Korsinsky by June 11, 2024 Deadline to Join Class Action Against QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)
NEW YORK, NY / ACCESSWIRE / April 23, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 23, 2024 05:30 am ET
QDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / April 23, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 22, 2024 06:30 pm ET
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Shareholders
NEW YORK, NY / ACCESSWIRE / April 22, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 22, 2024 06:30 pm ET
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 22, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 22, 2024 05:56 pm ET
QDEL INVESTOR ALERT: Securities Fraud Class Action Filed After QuidelOrtho (QDEL) Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 18, 2022 – Apr. 1, 2024Lead Plaintiff Deadline: June 11, 2024Visit:...
Apr 22, 2024 04:00 pm ET
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class Action - QDEL
NEW YORK, NY / ACCESSWIRE / April 22, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 22, 2024 03:20 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation (“QuidelOrtho”...
Apr 22, 2024 07:35 am ET
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 22, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 22, 2024 07:00 am ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 22, 2024 06:15 am ET
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - QDEL
NEW YORK, NY / ACCESSWIRE / April 22, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 22, 2024 06:15 am ET
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) should contact Levi & Korsinsky about pending Class Action - QDEL
NEW YORK, NY / ACCESSWIRE / April 22, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 22, 2024 05:45 am ET
QDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, April 22, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in QuidelOrtho Corporation f/k/a Quidel Corporation ("QuidelOrtho" or the "Company") (NASDAQ: QDEL) of a class action securities lawsuit.
Apr 22, 2024 05:00 am ET
Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - QDEL
NEW YORK, NY / ACCESSWIRE / April 22, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 22, 2024 04:00 am ET
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho (“QuidelOrtho” or “the Company”) (NASDAQ: QDEL) and certain of its...
Apr 22, 2024 04:00 am ET
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, April 22, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho ("QuidelOrtho" or "the Company") (NASDAQ: QDEL) and certain of its officers.
Apr 22, 2024 02:30 am ET
QuidelOrtho Corporation f/k/a Quidel Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / April 22, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 22, 2024 01:45 am ET
QUIDELORTHO CORPORATION (NASDAQ: QDEL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds QuidelOrtho Corporation Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL)?Did you purchase your shares between February 18, 2022 and April 1, 2024, inclusive?Did you lose money in your investment in...
Apr 21, 2024 08:00 am ET
Levi & Korsinsky Notifies Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / April 21, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 21, 2024 07:00 am ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 21, 2024 07:00 am ET
Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / April 21, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 20, 2024 07:02 pm ET
Levi & Korsinsky Notifies Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / April 20, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 19, 2024 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, and QuidelOrtho and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ocugen, Inc. (NASDAQ: OCGN), and QuidelOrtho Corporation (NASDAQ: QDEL)....
Apr 19, 2024 03:30 pm ET
Investors who lost money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) should contact Levi & Korsinsky about pending Class Action - QDEL
NEW YORK, NY / ACCESSWIRE / April 19, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 19, 2024 02:49 pm ET
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation (NASDAQ: QDEL) between February 18, 2022 and April 1, 2024, both dates...
Apr 19, 2024 12:45 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ:
Apr 19, 2024 12:45 pm ET
Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - QDEL
NEW YORK, NY / ACCESSWIRE / April 19, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 19, 2024 12:09 pm ET
DEADLINE ALERT for VFS, QDEL, and ASTS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Apr 19, 2024 09:15 am ET
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 19, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 19, 2024 07:00 am ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 19, 2024 06:40 am ET
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law Firm
NEW YORK, April 19, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL).
Apr 19, 2024 05:40 am ET
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / April 19, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 19, 2024 05:40 am ET
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / April 19, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 18, 2024 11:15 pm ET
Levi & Korsinsky Notifies Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 18, 2024 08:00 pm ET
Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 18, 2024 07:00 pm ET
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – QDEL
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 18, 2024 05:30 pm ET
QuidelOrtho Corporation f/k/a Quidel Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights – QDEL
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 18, 2024 12:50 pm ET
Levi & Korsinsky Reminds QuidelOrtho Corporation f/k/a Quidel Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 – QDEL
Levi & Korsinsky, LLP notifies investors in QuidelOrtho Corporation f/k/a Quidel Corporation ("QuidelOrtho" or the "Company") (NASDAQ: QDEL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of...
Apr 18, 2024 05:45 am ET
Levi & Korsinsky Reminds QuidelOrtho Corporation f/k/a Quidel Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 18, 2024 01:00 am ET
IMPORTANT DEADLINE ALERT: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 17, 2024 02:09 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ:
Apr 17, 2024 01:15 pm ET
QDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / April 17, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 17, 2024 12:41 pm ET
QuidelOrtho (QDEL) Securities Fraud Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 18, 2022 – Apr. 1, 2024Lead Plaintiff Deadline: June 11, 2024Visit:...
Apr 17, 2024 12:15 pm ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ:
Apr 17, 2024 10:30 am ET
Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL
NEW YORK, NY / ACCESSWIRE / April 17, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 17, 2024 10:08 am ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) and reminds investors of the June 11, 2024 deadline to seek the role of...
Apr 17, 2024 07:00 am ET
QuidelOrtho To Report First Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today it will report its financial results for its first quarter ended March 31, 2024, after the market close on Wednesday, May 8, 2024.
Apr 17, 2024 05:40 am ET
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 17, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 17, 2024 03:00 am ET
Investors who lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class Action - QDEL
NEW YORK, NY / ACCESSWIRE / April 17, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 17, 2024 02:31 am ET
Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against QuidelOrtho Corporation (QDEL)
Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL) common stock between February 18, 2022...
Apr 16, 2024 10:40 pm ET
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights – QDEL
NEW YORK, NY / ACCESSWIRE / April 16, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 16, 2024 10:05 pm ET
IMPORTANT DEADLINE ALERT: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 16, 2024 04:30 pm ET
Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - QDEL
NEW YORK, NY / ACCESSWIRE / April 16, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 16, 2024 02:55 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) common stock between February 18, 2022 and April 1, 2024, inclusive (the “Class Period”). QuidelOrtho investors have until June 11, 2024 to fil
Apr 16, 2024 01:15 pm ET
Levi & Korsinsky Reminds QuidelOrtho Corporation f/k/a Quidel Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL
NEW YORK, NY / ACCESSWIRE / April 16, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 16, 2024 12:31 pm ET
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation (NASDAQ: QDEL) between February 18, 2022 and April 1, 2024, both dates...
Apr 16, 2024 12:30 pm ET
Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / April 16, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Apr 15, 2024 11:32 pm ET
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, April 15, 2024 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho ("QuidelOrtho" or "the Company") (NASDAQ: QDEL) and certain of its officers.
Apr 15, 2024 06:47 pm ET
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho (“QuidelOrtho” or “the Company”) (NASDAQ: QDEL) and certain of its...
Apr 15, 2024 06:14 pm ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation (“QuidelOrtho” or “the Company”) (NASDAQ: QDEL) for violations of §§10(b) and 20(a) of the Securities...
Apr 15, 2024 05:38 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against QuidelOrtho Corporation (QDEL)
Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired...
Apr 15, 2024 12:13 pm ET
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation (NASDAQ: QDEL) between February 18, 2022 and April 1, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 11, 2024.
Apr 15, 2024 12:00 pm ET
QUIDELORTHO CORPORATION (NASDAQ: QDEL) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against QuidelOrtho Corporation
Bernstein Liebhard LLP: Do you, or did you, own shares of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL)?Did you purchase your shares between February 18, 2022 and April 1, 2024, inclusive?Did you lose money in your investment in...
Apr 15, 2024 03:00 am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Apr 15, 2024 02:30 am ET
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against QuidelOrtho Corporation and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) in the United States District...
Apr 13, 2024 01:44 pm ET
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Corporation and Certain Executives
Labaton Keller Sucharow LLP (“Labaton”) announces that, on April 12, 2024, it filed a securities class action lawsuit (the “Complaint”) on behalf of its client Bristol County Retirement System (“Bristol County”) against QuidelOrtho Corporation, formerly known as Quidel Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL), and certain QuidelOrtho officers (collectively, “Defendants”). The action, which is captioned Bristol County Retirement System v. QuidelOrtho Corporation, No. 24-cv-02804 (S.D.N.Y. Apr. 12, 2024), asserts claims under Sections 10(b) and 20(a) of the Secur
Apr 13, 2024 11:33 am ET
QuidelOrtho (QDEL) Securities Fraud Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 18, 2022 – Apr. 1, 2024Lead Plaintiff Deadline: June 11, 2024Visit:...
Apr 12, 2024 06:55 pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Apr 12, 2024 06:00 pm ET
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Company and Certain Executives
Labaton Keller Sucharow LLP (“Labaton”) announces that, on April 12, 2024, it filed a securities class action lawsuit (the “Complaint”) on behalf of its client Bristol County Retirement System (“Bristol County”) against QuidelOrtho Corporation, formerly known as Quidel Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL), and certain QuidelOrtho officers (collectively, “Defendants”). The action, which is captioned Bristol County Retirement System v. QuidelOrtho Corporation, No. 24-cv-02804 (S.D.N.Y. Apr. 12, 2024), asserts claims under Sections 10(b) and 20(a) of the Secur
Apr 11, 2024 03:30 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Apr 10, 2024 07:00 am ET
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”). This Fentanyl assay will help hospital and emergency room customers respond to the critical demand for enhanced opioid testing, allowing on-site fentanyl testing in less than 10 minutes to aid in immediate clinical decisions.
Apr 09, 2024 03:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Apr 08, 2024 04:52 pm ET
ROSEN, A LEADING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Apr 05, 2024 01:15 pm ET
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Apr 05, 2024 07:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Apr 04, 2024 03:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Apr 03, 2024 03:30 am ET
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Apr 02, 2024 09:00 am ET
QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho" or the “Company”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its QuickVue COVID-19 test. This clearance allows the test to be used with accuracy and convenience in home and medical facility settings with CLIA certificates of waiver. This achievement also reflects QuidelOrtho’s dedication to delivering effective testing solutions while highlighting ongoing efforts in research and development to enhance market competitiveness.
Apr 01, 2024 09:13 pm ET
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Mar 30, 2024 06:20 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ: QDEL) for violations of the securities laws.
Mar 28, 2024 01:17 pm ET
ROSEN, SKILLED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Mar 28, 2024 03:30 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Mar 27, 2024 03:30 am ET
IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Mar 24, 2024 04:43 pm ET
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Mar 22, 2024 03:30 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Mar 20, 2024 07:00 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Mar 17, 2024 12:41 pm ET
ROSEN, LEADING INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Mar 14, 2024 05:00 pm ET
ROSEN, A LEADING NATIONAL FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Mar 14, 2024 04:13 pm ET
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of the securities laws.
Mar 07, 2024 03:43 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of QuidelOrtho Corporation - QDEL
Pomerantz LLP is investigating claims on behalf of investors of QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Mar 07, 2024 02:11 pm ET
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Mar 06, 2024 04:35 pm ET
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received approval from Health Canada for its Triage PLGF test for laboratory use in Canada. The Triage PLGF test is a fluorescence immunoassay to be used with the small footprint Triage MeterPro® Instrument for the quantitative determination of placental growth factor (“PLGF”) in maternal plasma specimens. The test is intended to detect the presence of angiogenic imbalance, a consequen
Mar 03, 2024 11:00 pm ET
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of QuidelOrtho Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) on behalf of QuidelOrtho stockholders. Our...
Mar 03, 2024 10:35 am ET
ROSEN, LEADING INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Feb 29, 2024 06:28 pm ET
QDEL ALERT: ROSEN, A RESPECTED AND LEADING FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued...
Feb 28, 2024 05:10 pm ET
QDEL LOSS ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL) resulting from allegations that QuidelOrtho may have issued materially misleading business information to the investing public.
Feb 28, 2024 03:33 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of QuidelOrtho Corporation - QDEL
Pomerantz LLP is investigating claims on behalf of investors of QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....
Feb 26, 2024 04:30 pm ET
QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced that members of its management team are scheduled to participate in the 45th Annual Raymond James Institutional Investor Conference on March 5, 2024, in Orlando, FL.
Feb 26, 2024 04:00 am ET
QuidelOrtho Corporation (QDEL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of QuidelOrtho Corporation (“QuidelOrtho” or “the Company”) (NASDAQ: QDEL). Investors who purchased QuidelOrtho securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/QD
Feb 24, 2024 10:00 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of QuidelOrtho Corporation - QDEL
NEW YORK, Feb. 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") (NASDAQ: QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. 
Feb 22, 2024 12:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of QuidelOrtho Corporation (QDEL) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ:
Feb 21, 2024 08:36 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of QuidelOrtho Corporation (QDEL) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) investors concerning the Company’s possible violations of federal securities laws.
Feb 21, 2024 06:06 pm ET
QuidelOrtho: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises QuidelOrtho Corporation ("QuidelOrtho" or the "Company") (NASDAQ: QDEL) investors that the firm has initiated an investigation into possible securities violations and may file a class action on behalf of investors....
Feb 21, 2024 06:02 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of QuidelOrtho Corporation (QDEL) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ:
Feb 21, 2024 12:46 pm ET
QuidelOrtho CEO Terminated: Johnson Fistel Continues Investigation
Shareholder rights law firm Johnson Fistel, LLP is investigating whether QuidelOrtho Corporation ("QuidelOrtho" or the "Company") (NASDAQ: QDEL) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
Feb 21, 2024 07:30 am ET
QuidelOrtho Announces Changes in Executive Leadership
The Board of Directors (the “Board”) of QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”) has made significant decisions aimed to enhance operational efficiency, drive revenue growth and deliver shareholder value.
Feb 20, 2024 04:46 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of QuidelOrtho Corporation - QDEL
Pomerantz LLP is investigating claims on behalf of investors of QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....
Feb 20, 2024 01:49 pm ET
QuidelOrtho (QDEL) Stock Crashes After Posting YoY Revenue Decline, Analyst Downgrades - Hagens Berman
Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/QDELContact An Attorney Now: [email protected]  844-916-0895 QuidelOrtho...
Feb 15, 2024 04:40 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of QuidelOrtho Corporation - QDEL
NEW YORK, Feb. 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") (NASDAQ: QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Feb 14, 2024 08:34 pm ET
QuidelOrtho (QDEL) Stock Crashes After Posting YoY Revenue Decline, Analyst Downgrades - Hagens Berman
Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/QDEL Contact An Attorney Now: [email protected]...
Feb 14, 2024 02:24 pm ET
Berman Tabacco Announces Investigation of QuidelOrtho Corporation (QDEL) for Potential Securities Law Violations
Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL). About the Investigation On February 14, 2024, Bloomberg...
Feb 14, 2024 10:20 am ET
QDEL NEWS: Johnson Fistel has Commenced an Investigation on Behalf of QuidelOrtho Shareholders
Shareholder rights law firm Johnson Fistel, LLP is investigating whether QuidelOrtho Corporation ("QuidelOrtho" or the "Company") (NASDAQ: QDEL) or any of its executive officers or others violated securities laws by misrepresenting or failing to...
Feb 13, 2024 04:05 pm ET
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
“In our first full year operating as a combined company, we successfully laid the foundation for building a broader-based diagnostics company poised for future growth. We are encouraged by the growth in our non-respiratory business, the market share gains we are seeing in our respiratory portfolios, and the U.S. launch of our Savanna molecular platform. Our competitive positions are strong across the globe, and we believe our pipeline of innovative new products and menu expansions will continue to strengthen pull-through across our growing installed base,” said Douglas Bryant, President and Ch
Jan 23, 2024 07:00 am ET
QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2023, after the market close on Tuesday, February 13, 2024.
Dec 22, 2023 07:00 am ET
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
QuidelOrtho Corporation (NASDAQ:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced that Douglas Bryant, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024, in San Francisco, CA, scheduled for 12:00 p.m. ET / 9:00 a.m. PT.
Dec 20, 2023 04:05 pm ET
QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received 510(K) clearance from the U.S. Food and Drug Administration for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test for the detection and differentiation of Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2) and Varicella-zoster virus (VZV) nucleic acids isolated and purified from swabs obtained from cutaneous or mucoc
Nov 16, 2023 05:05 pm ET
QuidelOrtho to Participate in the Evercore ISI Conference
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the Evercore ISI conference in Miami, FL, on November 30, 2023.
Nov 01, 2023 04:05 pm ET
QuidelOrtho Reports Third Quarter 2023 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the third quarter ended October 1, 2023.
Oct 17, 2023 03:43 pm ET
Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times Square
Global Lyme Alliance (GLA), a leading nonprofit, produces chronic Lyme PSA with generous sponsorship from QuidelOrtho to ensure the broad visibility of this crucial message.
Oct 12, 2023 07:00 am ET
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced strong preliminary unaudited revenue results for the fiscal third quarter ended October 1, 2023, primarily driven by higher respiratory product sales, particularly SARS and flu.
Sep 21, 2023 04:05 pm ET
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has been granted CLIA Waiver from the U.S. Food and Drug Administration (FDA), applying to its new Sofia® 2 SARS Antigen+ FIA. The Sofia 2 SARS Antigen+ FIA is the first rapid antigen test that detects COVID-19 to be awarded FDA market clearance through the FDA’s De Novo process and is now the first rapid antigen test also to receive CLIA waiver. The test is intended f
Aug 28, 2023 04:05 pm ET
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the Morgan Stanley 21st Annual Global Healthcare Conference in New York on September 12, 2023.
Aug 08, 2023 04:30 pm ET
QuidelOrtho Reports Second Quarter 2023 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the second quarter ended July 2, 2023.
Jul 25, 2023 04:00 pm ET
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has earned the No. 1 ranking in the diagnostics industry for Overall Customer Satisfaction in the 2023 IMV ServiceTrak Awards for the sixth consecutive year. The ranking is based on interviews conducted with laboratory professionals, including QuidelOrtho’s customers, from more than 1,200 clinical testing locations operating over 1,900 collective instruments. The pres
Jul 25, 2023 01:12 pm ET
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has entered into a software development partnership with BYG4lab®, a leading provider of middleware and data management solutions for laboratories, that intends to accelerate QuidelOrtho’s efforts to expand and strengthen informatics offerings across its portfolio of diagnostics platforms.
Jul 24, 2023 03:00 pm ET
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has entered into a software development partnership with BYG4lab®, a leading provider of middleware and data management solutions for laboratories, that intends to accelerate QuidelOrtho’s efforts to expand and strengthen informatics offerings across its portfolio of diagnostics platforms.
Jul 18, 2023 04:05 pm ET
QuidelOrtho to Report Second Quarter 2023 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will report its financial results for its second quarter 2023 ended July 2, 2023, after the market close on Tuesday, August 8, 2023.
May 23, 2023 07:00 am ET
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the William Blair 43rd Annual Growth Stock Conference in Chicago, Illinois, on June 6, 2023.
May 03, 2023 04:05 pm ET
QuidelOrtho Reports First Quarter 2023 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the first quarter ended April 2, 2023.
Apr 13, 2023 04:05 pm ET
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary revenue results for the first quarter ended April 2, 2023.
Mar 28, 2023 11:05 am ET
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, celebrates Women’s History Month by announcing that the QuidelOrtho Women’s Leadership Network (QWLN) has been formed, creating an enhanced network with 14 global leaders supporting 16 chapters around the world.
Mar 08, 2023 04:05 pm ET
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has been granted a De Novo request from the U.S. Food and Drug Administration (FDA), allowing the company to market its new Sofia® 2 SARS Antigen+ FIA. The Sofia 2 SARS Antigen+ FIA is the first rapid antigen test that detects COVID-19 to be awarded FDA market clearance. The test is intended for prescription use only and can be used in point-of-care settings.
Mar 02, 2023 02:01 pm ET
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference in Orlando, Florida, on March 7, 2023.
Feb 27, 2023 10:00 am ET
ImageMover and QuidelOrtho Partner to Simplify Test-to-Treat Process for Pharmacies
MADISON, Wis., Feb. 27, 2023 /PRNewswire/ -- ImageMover, a provider of Workflow Services for pharmacies, is proud to announce its partnership with QuidelOrtho, a leading provider of point-of-care diagnostic testing solutions, to bring a comprehensive solution for pharmacist-administered testing for a variety of illnesses, including COVID-19, influenza A+B, Lyme disease, strep throat, and RSV. This revolutionary combination of diagnostic hardware and customized software offers patients fast and accurate results and simplifies the test-to-treat process for pharmacists.
Feb 15, 2023 04:05 pm ET
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the fourth quarter ended January 1, 2023.
Jan 06, 2023 04:05 pm ET
QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary unaudited revenue results for the fourth quarter and full year ended January 1, 2023.
Dec 28, 2022 07:00 am ET
QuidelOrtho to Present at the J.P. Morgan Healthcare Conference
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco beginning on January 9, 2023, with a presentation scheduled for 9:00 a.m. PST / 12:00 p.m. EST.
Dec 19, 2022 03:15 pm ET
Health Canada Grants License for Quidel® TriageTrue® High-Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that Health Canada has approved for use in Canada the Quidel TriageTrue High-Sensitivity Troponin I (hsTnl) Test on the Quidel Triage® MeterPro®, a high-performance, comprehensive testing platform with the smallest footprint analyzer, to aid in the diagnosis of myocardial infarction. The Quidel TriageTrue hsTnl Test effectively and safely offers fast turnaround time with a res
Dec 16, 2022 11:05 am ET
QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho” or the “Company”), a global provider of innovative in vitro diagnostics (IVD) technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today the signing of a definitive agreement to form a joint venture (JV) between Ortho Clinical Diagnostics Trading (China) Co., Ltd., a subsidiary of QuidelOrtho, and Shanghai Medconn Biotechnology Co., Ltd., a subsidiary of Shanghai Runda Medical Technology Co., Ltd. (“Runda Medical”) to develop and manufacture assays in China for QuidelOrtho’s VITROS® plat
Dec 12, 2022 04:54 pm ET
QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho” or the “Company”), a global provider of innovative in vitro diagnostic (IVD) technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that its Board of Directors (the “Board”) has appointed Dr. Kenneth F. Buechler, Lead Independent Director, to non-executive Chairman, effective December 11, 2022. The separation of the Chairman and Chief Executive Officer roles is a key step toward strengthening the Company’s governance practices and will facilitate the right balance between strong and
Nov 30, 2022 04:05 pm ET
QuidelOrtho to Host Investor Day on December 13, 2022
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will host an Investor Day on Tuesday, December 13, 2022, starting at 1:00 p.m. ET / 10:00 a.m. PT at Convene at Nasdaq MarketSite, 151 West 42nd Street, New York, NY 10036.
Nov 02, 2022 04:05 pm ET
QuidelOrtho Reports Third Quarter 2022 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the third quarter ended October 2, 2022.
Oct 12, 2022 04:05 pm ET
QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022
QuidelOrtho Corporation (NASDAQ: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary revenue results for the third quarter ended October 2, 2022.
Oct 04, 2022 09:00 am ET
Development of New Drugs to Target Lyme and Other Infectious Diseases Subject of a New Webinar Now Available From Quidel Corporation
Lyme disease is the fastest-growing vector-borne disease in the United States, and its increased prevalence is challenging the scientific community to look for new ways to diagnose and treat this worrisome infection. One answer is found in the discovery of novel drugs; and the breakthrough efforts taking place in this arena are the subject of a new webinar made available by Quidel Corporation, the California-based diagnostic health care manufacturer known for successfully developing rapid diagnostic health solutions.
Sep 06, 2022 08:00 am ET
QuidelOrtho to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the Morgan Stanley 20th Annual Global Healthcare Conference in New York beginning on September 12, 2022, with a fireside chat scheduled for 4:50 p.m. ET / 1:50 p.m. PT.
Sep 01, 2022 12:00 pm ET
Quidel and World Champion Los Angeles Rams Partner to Combat COVID-19 and Promote Health Awareness in the L.A. Community
Quidel Corporation (“Quidel”), a subsidiary of QuidelOrtho Corporation (NASDAQ: QDEL) and a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and the World Champion Los Angeles Rams today announced a multi-year partnership agreement to promote health awareness and COVID-19 testing. The agreement makes Quidel an “Official Partner of the Los Angeles Rams” and designates Quidel’s QuickVue at-home rapid antigen test as the “Official At-Home COVID Test of the Los Angeles Rams.” In addition, the partnership includes a vari
Aug 24, 2022 09:00 am ET
Bacterial Biofilms, Responsible for Up to 75% of All Infectious Diseases in America, Explored in New Webinar From Quidel Corporation
The National Institutes of Health reports that bacterial biofilms are responsible for up to 75% of all infectious diseases in humans, including infections of wounds, the lungs and the urinary tract. This important medical reality is now being addressed in a new webinar made available by Quidel Corporation, the California-based diagnostic health care manufacturer known for successfully developing rapid diagnostic health solutions.
Aug 17, 2022 04:30 pm ET
QuidelOrtho Announces $300 Million Share Repurchase Authorization
QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that its board of directors has authorized the repurchase of up to $300 million of shares of QuidelOrtho’s common stock over the next two years.
Aug 04, 2022 04:10 pm ET
QuidelOrtho Reports Second Quarter 2022 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a leading in vitro diagnostics company, today announced financial results for the second quarter ended July 3, 2022.
Jul 26, 2022 09:35 am ET
ORTHO RANKS NO. 1 IN CUSTOMER SATISFACTION FOR 5 YEARS IN A ROW
Company receives top customer rating in the 2022 IMV ServiceTrak™ Awards
Jul 26, 2022 09:35 am ET
ORTHO RANKS NO. 1 IN CUSTOMER SATISFACTION FOR 5 YEARS IN A ROW
Company receives top customer rating in the 2022 IMV ServiceTrak™ Awards
Jul 18, 2022 04:05 pm ET
QuidelOrtho to Report Second Quarter 2022 Financial Results on August 4, 2022
QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a leading in vitro diagnostics company, today announced it will report financial results for its second quarter 2022 ended July 3, 2022, after the market close on Thursday, August 4, 2022....
Jun 21, 2022 07:00 pm ET
Quidel Corporation and the American Heart Association join forces to Advance Education and Awareness of Heart Disease in San Diego County
QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) — QuidelOrtho announces that its subsidiary, Quidel Corporation, is collaborating with the American Heart Association, the leading voluntary health organization devoted to a world of longer and healthier lives, to improve the health of San Diego residents and deconstruct barriers to equitable health in our communities. Quidel Corporation will invest funding totaling $750,000 and support over the next three years as the American Heart Association approaches their centennial anniversary in 2024.
Jun 09, 2022 09:00 am ET
Quidel Corp.—Developer of Only FDA-Cleared FIA Rapid Point-of-Care Diagnostic Lyme Disease Test—To Partner With Renowned Global Lyme Alliance to Dramatically Heighten Lyme Disease Awareness
With Lyme disease season in full-swing across the United States and as the public continues spending increasing time outdoors during the COVID-19 pandemic, Quidel’s recently formed Lyme Task Force Team—the only one of its kind—today announced a multitiered collaboration with Global Lyme Alliance to dramatically heighten public awarenes
May 27, 2022 09:00 am ET
QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics
QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated more than $3.5 billion in combined revenues in 2021 and has approximately 6,000 employees. QuidelOrtho will trade on the Nasdaq Global Select Market under the symbol “QDEL.”
May 26, 2022 12:24 pm ET
Quidel and Ortho Announce Expected Closing of Ortho Transaction
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc (“Ortho”), one of the world’s larger...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.